已收录 268921 条政策
 政策提纲
  • 暂无提纲
Venous thromboembolism and persistent pulmonary hypertension in cancer patients: a cross-sectional study
[摘要] BackgroundCancer patients are at increased risk for venous thromboembolism (VTE).ObjectiveThis monocenter cross-sectional study prospectively assessed the association between a history of ≥1 VTE episode and the presence of pulmonary hypertension (PH) among cancer patients presenting with pulmonary or cardiac symptoms.MethodsA consecutive series of 583 patients underwent a diagnostic work-up for heart and lung disease. PH was diagnosed if a patient’s peak systolic pressure gradient across the tricuspid valve was ≥35 mmHg, as measured by echocardiography. Using multiple logistic regression analysis, the association between VTE and PH was assessed, following adjustments for age, the presence of severe airway obstruction, atrial fibrillation and left heart diseases.ResultsThe prevalence values for PH (n = 90) and a history of VTE (n = 72) were 15.4 and 12.3 %, respectively. The median time interval between the first VTE episode and referral was 43 months. The odds of PH was higher in the subgroup with VTE (19/72; 26.4 %) than that without VTE (71/511; 13.9 %) in the unadjusted analysis [odds ratio (OR) 2.2, 95 % confidence interval (CI) 1.2, 4.0] and the adjusted model [OR 2.4, 95 % CI 1.2, 4.5]. The risk of PH did not depend on the time interval between VTE and referral. Older age and the presence of severe airway obstruction, atrial fibrillation, and left heart diseases were also associated with an increased odds of PH.ConclusionIn cancer patients presenting with cardiac or pulmonary symptoms, previous VTE is associated with an increased risk of persistent PH.
[发布日期] 2016-02-08 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Venous thromboembolism;Pulmonary hypertension;Cancer;Heart disease [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文